Objective: This study aims at presenting prenatal diagnosis of mosaic trisomy 2 and reviewing the literature. Materials, Methods, and Results: A 32-year-old woman underwent amniocentesis at 21 weeks of gestation because of abnormal maternal serum biochemistry. Amniocentesis revealed a karyotype of 47,XY,þ2[1]/46,XY [21] in in situ cultures. The single colony with trisomy 2 had two metaphase cells, and both had the karyotype of 47,XY,þ2. Repeated amniocentesis was performed at 23 weeks of gestation. Interphase fluorescence in situ hybridization (FISH) analysis on uncultured amniocytes using a 2q11.1-specific probe RP11-468G5 (spectrum green) showed three green signals in 11 of 47 uncultured amniocytes, indicating 23.4% mosaicism for trisomy 2. The cultured amniocytes had a karyotype of 46,XY[20 colonies]. Polymorphic DNA marker analysis excluded uniparental disomy 2. The woman underwent the third amniocentesis at 25 weeks of gestation. Interphase FISH analysis on uncultured amniocytes revealed 9.4% (5/53 cells) mosaicism for trisomy 2. The cultured amniocytes had a karyotype of 46,XY[30 colonies]. Prenatal ultrasound was normal. The parents decided to continue the pregnancy to term, and a 3316-g baby was delivered with no phenotypic abnormalities. Cord blood had a karyotype of 46,XY[40 cells]. Interphase FISH analysis on uncultured urinary cells revealed 8.2% (4/49 cells) mosaicism for trisomy 2. The neonate was normal in growth and psychomotor development at 6 months of age. Conclusion: Prenatal diagnosis of a single colony with two or more cells with trisomy 2 at amniocentesis should alert a clinically significant aneuploidy, and interphase FISH on uncultured amniocytes is useful for rapid confirmation of low-level trisomy 2 mosaicism at amniocentesis. The abnormal cell line of trisomy 2 may disappear after long-term amniocyte cultures.
Introduction
Complete trisomy 2 or nonmosaic trisomy 2 is lethal and has been found in 1% to 5e6% of first-trimester spontaneous abortions [1, 2] . The prevalence of mosaic trisomy 2 in chorionic villus sampling has been estimated to be one in 2000 samplings [3e6] . Prenatal diagnosis of mosaic trisomy 2 by amniocentesis is uncommon. Sago et al [7] found one case of true cytogenetic trisomy 2 mosaicism among 58,000 amniocenteses. Mosaic trisomy 2 has phenotypic and cytogenetic variability (Table 1) . Characteristic phenotypic features in abnormal livebirths with mosaic trisomy 2 include intrauterine growth restriction (IUGR), microcephaly, midface hypoplasia, hypertelorism, cleft lip, cleft palate, widely spaced nipples, radioulnar hypoplasia, scoliosis, growth and motor delay, inguinal hernia, congenital diaphragmatic hernia, rockerbottom feet, cardiac defects, neural tube defects, intestinal malrotation, portal fibrosis, bronchopulmonary dysplasia, hypomelanosis of Ito, caudal dysgenesis, Hirschsprung disease, and micro-anophthalmia [7,9e12,15,19e22] . Herein, we present our experience of prenatal diagnosis of mosaic trisomy 2 by amniocentesis and a review of the literature.
Materials, methods, and results
A 32-year-old, primigravid woman underwent amniocentesis at 21 weeks of gestation because of an abnormal result of second-trimester maternal serum screening. The maternal serum biochemistry at 15 weeks of gestation revealed a Down syndrome risk of 1/149 calculated from the levels of 0.56, 0.94, 1.09, and 1.76 multiples of the median (MoM) for afetoprotein (AFP), unconjugated estriol (uE3), total b-human chorionic gonadotrophin (b-hCG), and inhibin-A, respectively. Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XY,þ2 [1] /46,XY [21] . Of 22 colonies of cultured amniocytes, one colony had the karyotype of 47,XY,þ2, whereas the other 21 colonies had the karyotype of 46,XY (Fig. 1) . The single colony with trisomy 2 had two metaphase cells, and each cell had a karyotype of 47,XY,þ2. The parental karyotypes were normal, and prenatal ultrasound findings were unremarkable. Repeated amniocentesis was performed at 23 weeks of gestation. Array comparative genomic hybridization (aCGH), interphase fluorescence in situ hybridization (FISH), and quantitative fluorescent polymerase chain reaction (QF-PCR) were applied on uncultured amniocytes, and conventional cytogenetic analysis was applied on cultured amniocytes. The aCGH analysis on uncultured amniocytes revealed no genomic imbalance in chromosome 2. Interphase FISH analysis on uncultured amniocytes using a 2q11.1-specific probe of RP11-468G5 (spectrum green) showed three green signals in 23.4% (11/47 cells) and two green signals in 76.6% (36/47 cells) of uncultured amniocytes (Fig. 2) . QF-PCR analysis on uncultured amniocytes using chromosome 2-specific microsatellite markers revealed a 1:1 biparental diallelic pattern for chromosome 2 and thus excluded uniparental disomy (UPD) 2 (Fig. 3) (Fig. 5) . The neonate was normal in growth and psychomotor development at 6 months of age.
Discussion
The present case provides evidence for the usefulness of application of interphase FISH on uncultured amniocytes for rapid confirmation of low-level trisomy 2 mosaicism at amniocentesis. The present case also provides evidence that the abnormal cell line of trisomy 2 in cases with mosaic trisomy 2 may disappear after long-term cell cultures. Trisomy 2 mosaicism at amniocentesis has been associated with pseudomosaicism [23] and also with a discrepancy between molecular cytogenetic analyses of uncultured amniocytes and karyotyping of cultured amniocytes [18] . The present case had trisomy 2 in both the metaphase cells of a single colony. According to modified guidelines for the management of cases with suspected amniocyte mosaicism, autosomal trisomy involving a chromosome 2, 5, 8, 9, 12, 13, 14, 15, 16, 18, 20, 21 , or 22 in a single colony (single dish) or in multiple colonies (single dish) in an in situ culture method is an indication for extensive workup requiring the examination of 24 colonies from two further separate cultures [24] . The Association for Clinical Cytogenetics [25] has suggested that particular care should be taken in interpreting level II mosaicism (2 or more cells with the same abnormality in a suspicion culture from a single flask, or in a single abnormal colony from an in situ culture) for a clinically significant aneuploidy, and interphase FISH may be used for the investigation of mosaicism in a prenatal setting. The present case shows that interphase FISH on uncultured amniocytes in repeated amniocentesis is very practical for differential diagnosis of true mosaicism from pseudomosaicism under such a circumstance. We suggest that interphase FISH is the molecular cytogenetic method of choice for rapid confirmation of lowlevel mosaicism at amniocentesis. In the present case, the first amniocentesis revealed 4.5% (1/22 colonies) mosaicism for trisomy 2 in cultured amniocytes, the second amniocentesis revealed a normal 46,XY karyotype in all 20 colonies of cultured amniocytes, and the third amniocentesis revealed a normal 46,XY karyotype in all 30 colonies of cultured amniocytes. However, at the second amniocentesis, the To date, at least 18 cases of mosaic trisomy 2 detected by amniocentesis have been reported (Table 1 ). Of these, at least nine cases (50%) [6e8, 10,12e15,18] were associated with prominent phenotypic abnormalities, suggesting that the malformation risk should be concerned in prenatal diagnosis of mosaic trisomy 2 by amniocentesis. Table 1 shows that the male:female sex ratio for fetal mosaic trisomy 2 is 1.8 (11 males/6 females), indicating a male preponderance in fetal mosaic trisomy 2 and a natural selection against female mosaic trisomy 2 conceptuses. Table 1 also shows that mosaic trisomy 2 can prenatally be associated with elevated maternal serum AFP (MSAFP), abnormal maternal serum screening, and abnormal ultrasound findings. Golabi et al [10] and Sago et al [7] reported an elevated MSAFP level of 2.93 MoM in a pregnancy with mosaic trisomy 2, congenital heart defects, IUGR, and hydronephrosis. Pappas et al [12] reported an elevated amniotic fluid AFP level of 13 standard deviations above the mean with positive acetylcholinesterase in a pregnancy with mosaic trisomy 2, lumbosacral spina bifida, and ventriculomegaly. Hsu et al [14] reported a pregnancy with an elevated MSAFP level of 4 MoM, fetal mosaic trisomy 2, dolichocephaly, and oligohydramnios, and another case with elevated MSAFP, fetal mosaic trisomy 2, and stillbirth. Harrison et al [11] reported an elevated maternal serum human chorionic gonadotrophin (MShCG) level of 3.67 MoM, indicating a 1:145 risk of Down syndrome in a pregnancy with mosaic trisomy 2 and maternal UPD 2. Robinson et al [15] reported a raised Down syndrome risk of 1:90 on maternal serum screening for AFP and hCG in a pregnancy with mosaic trisomy 2 and multiple anomalies. Roberts et al [16] reported an elevated MSAFP level of 3.67 MoM and an elevated MShCG level of 3.9 MoM in a pregnancy with mosaic trisomy 2, IUGR, and oligohydramnios. The present case was associated with abnormal maternal serum screening for AFP, uE3, total b-hCG, and inhibin-A, and a 1:145 risk of Down syndrome. Table 1 additionally shows that the reported abnormal ultrasound findings associated with mosaic trisomy 2 at amniocentesis include IUGR, oligohydramnios, congenital heart defects, ventriculomegaly, spina bifida, and hydronephrosis.
Mosaic trisomy 2 detected postnatally has been described in four cases [19e22] , and there exists phenotypic and cytogenetic variability. Cramer et al [19] first reported a 6-monthold girl with 40% trisomy 2 mosaicism in skin fibroblasts and a normal 46,XX karyotype in 100 lymphocytes. The girl manifested IUGR, gross motor and growth delay, scoliosis, unilateral radioulnar hypoplasia, craniosynostosis, broad halluces, radial deviation of the wrist, frontal bossing, unilateral proptosis, and contralateral ptosis. Gupta et al [20] reported a 3-month-old girl with mosaic trisomy 2, normal perinatal findings, normal development, and normal growth. The girl manifested hypomelanosis of Ito. Her blood karyotype was normal, but the skin biopsy and cell culture in skin fibroblasts over the area of pigmentation showed a karyotype of 47,XX,þ2 [9] /46,XX [11] . Mihci et al [21] reported a girl aged 2.5 years with multiple congenital anomalies, 3% (3/100 cells) trisomy 2 mosaicism in skin fibroblasts, and a normal 46,XX karyotype in peripheral blood. The girl was found to have large kidneys and diaphragmatic hernia on prenatal ultrasound. She had a history of diaphragmatic hernia, duodenal atresia, intestinal malrotation, microcephaly, atrial and ventricular septal defects, developmental delay, hypotonia, and seizures. She manifested microbrachycephaly, a receded frontal hair line, a dysmorphic face with small and wide-set eyes, epicanthic folds, midface hypoplasia, thin upper lip, small mouth, down-turned corners of the mouth, a prominent [28] reported a 34-gestational-week acardiac twin with a karyotype of 47,XY,þ2 in the skin. Blaicher et al [29] reported a term acardiac twin with a karyotype of 47,XX,þ2 in the skin. Seller et al [30] reported a 13-gestational-week fetus with microcephaly, iniencephaly, encephalocele, thoracic spina bifida, a karyotype of 47,XY,þ2 in the umbilical cord, and trisomy 2 in the skin by interphase FISH. Mihci et al [21] reported a term acardiac twin with a karyotype of 47,XX,þ2 in the skin.
Mosaic trisomy 2 at amniocentesis can be associated with mosaic trisomy 2 or complete trisomy 2 in the placenta (Table 1) . High-level trisomy 2 mosaicism and complete trisomy 2 in the placenta with or without fetal UPD 2 have been well known to be associated with IUGR, oligohydramnios, and adverse fetal outcome [6,13,15,18,31e36] . The presence of trisomy 2 in amnion has additionally been found to correlate with poor pregnancy outcome even when the fetus has a normal karyotype [36] . Mosaic trisomy 2 at amniocentesis has always been associated with a normal karyotype in the blood. Therefore, cord blood sampling for rapid confirmation of mosaic trisomy 2 at amniocentesis is not practical.
In summary, we present prenatal diagnosis and molecular cytogenetic analysis of mosaic trisomy 2 using uncultured and cultured amniocytes in a pregnancy with favorable fetal outcome. We demonstrate the usefulness of interphase FISH on uncultured amniocytes for rapid confirmation of low-level trisomy 2 mosaicism at amniocentesis and provide evidence that the abnormal cell line of trisomy 2 may disappear after long-term amniocyte cultures. 
